×
About 18,294 results

ALLMedicine Ankylosing Spondylitis Center

Research & Reviews  7,343 results

Early detection of ankylosing spondylitis using texture features and statistical machin...
https://doi.org/10.1016/j.compmedimag.2020.101718
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society; Castro-Zunti R, Park EH et. al.

May 28th, 2020 - Ankylosing spondylitis (AS) is an arthritis with symptoms visible in medical imagery. This paper proposes, to the authors' best knowledge, the first use of statistical machine learning- and deep learning-based classifiers to detect erosion, an ear...

Risk for development of inflammatory bowel disease under inhibition of interleukin 17: ...
https://doi.org/10.1371/journal.pone.0233781
PloS One; Burisch J, Eigner W et. al.

May 27th, 2020 - Cases of inflammatory bowel disease (IBD) during treatment with interleukin (IL)-17 antagonists have been reported from trials in psoriasis, psoriatic arthritis, and ankylosing spondylitis. The aim of this study was to assess the overall risk for ...

Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in ...
https://doi.org/10.1007/s00296-020-04607-3
Rheumatology International; Miler M, Nikolac Gabaj N et. al.

May 26th, 2020 - Vitamin D is beneficial in patients with immune-mediated rheumatic diseases as it has been shown that it lowers the incidence risk and the level of inflammation. To examine the association between clinical outcomes and initial 25-hydroxyvitamin D ...

Spondyloarthritis evolution: what is in your history?
https://doi.org/10.1097/BOR.0000000000000712
Current Opinion in Rheumatology; Ashrafi M, Ermann J et. al.

May 26th, 2020 - This review encompasses a detailed history of spondyloarthritis (SpA) evolution as early as the 17th century, continues on to the current concept of SpA, and ends with current gaps in our understandings of SpA. Until the early 1960s, ankylosing sp...

Down-regulated miR-495 can target programmed cell death 10 in ankylosing spondylitis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249445
Molecular Medicine (Cambridge, Mass.); Ni WJ, Leng XM

May 26th, 2020 - MicroRNAs (miRNAs) play crucial roles in regulating eukaryotic gene expression. Recent studies indicated that aberrantly expressed miRNAs are involved in the pathogenesis of ankylosing spondylitis (AS). Indeed, hsa-miR-495-3p (miR-495) has been re...

see more →

Guidelines  37 results

2019 Update of the American College of Rheumatology/ Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis ...
https://www.rheumatology.org/Portals/0/Files/AxialSpA-Guideline-2019.pdf
Ward MM,et al

Sep 30th, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). ankylosing spondylitis

2019 Update of the American College of Rheumatology/Spondylitis Association of America/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.

Aug 22nd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...

FDA Approves Samsung Bioepis' HADLIMA™ (adalimumab-bwwd)
https://www.businesswire.com/news/home/20190723006033/en/FDA-Approves-Samsung-Bioepis-HADLIMA%E2%84%A2-adalimumab-bwwd

Jul 23rd, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® i (adalimumab), for the treatment of rheumatoid arthritis, juvenile idiopathic arthr...

FDA Approves ETICOVO™ (etanercept-ykro), Samsung Bioepis' Second Anti-TNF Medicine in the United States
http://www.samsungbioepis.com/en/newsroom/detail/FDA-Approves-ETICOVO-Samsung-Bioepis-Second-Anti-TNF-Medicine.html

Apr 28th, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved ETICOVO™ (etanercept-ykro), a biosimilar referencing ENBREL® (etanercept), across all eligible indications for the treatment of rheumatoid arthri...

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guidelin...
https://www.rheumatology.org/Portals/0/Files/ACR-AAHKS-Perioperative-Management-Guideline.pdf
Goodman, S.,et al

Jul 31st, 2017 - This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid a.

see more →

Drugs  965 results see all →

Clinicaltrials.gov  8,965 results

FDA Approves Ixekizumab (Taltz) for Nonradiographic Axial Spondyloarthritis
https://www.medscape.com/viewarticle/931543

May 31st, 2020 - The Food and Drug Administration has extended approval of ixekizumab (Taltz) to the treatment of nonradiographic axial spondyloarthritis (nr-axSpA), according to a press release from its manufacturer, Eli Lilly. Specifically, this supplemental bio...

Diclofenac sodium delayed release - diclofenac sodium tablet, delayed release-Denton Pharma, Inc. DBA Northwind Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7cb16c66-a781-60f7-e053-2991aa0ac77c

May 31st, 2020 - Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac. Use the lowest effective dose for the shortest duration consistent with individual pati...

Early detection of ankylosing spondylitis using texture features and statistical machin...
https://doi.org/10.1016/j.compmedimag.2020.101718
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society; Castro-Zunti R, Park EH et. al.

May 28th, 2020 - Ankylosing spondylitis (AS) is an arthritis with symptoms visible in medical imagery. This paper proposes, to the authors' best knowledge, the first use of statistical machine learning- and deep learning-based classifiers to detect erosion, an ear...

Sulindac - sulindac tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ddbbaada-f55a-4032-a24c-a8c493933a45

May 28th, 2020 - Carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS )...

Risk for development of inflammatory bowel disease under inhibition of interleukin 17: ...
https://doi.org/10.1371/journal.pone.0233781
PloS One; Burisch J, Eigner W et. al.

May 27th, 2020 - Cases of inflammatory bowel disease (IBD) during treatment with interleukin (IL)-17 antagonists have been reported from trials in psoriasis, psoriatic arthritis, and ankylosing spondylitis. The aim of this study was to assess the overall risk for ...

see more →

News  933 results

FDA Approves Ixekizumab (Taltz) for Nonradiographic Axial Spondyloarthritis
https://www.medscape.com/viewarticle/931543

May 31st, 2020 - The Food and Drug Administration has extended approval of ixekizumab (Taltz) to the treatment of nonradiographic axial spondyloarthritis (nr-axSpA), according to a press release from its manufacturer, Eli Lilly. Specifically, this supplemental bio...

Fast Five Quiz: Nonradiographic Axial Spondyloarthritis
https://www.medscape.com/viewarticle/924109

May 27th, 2020 - Ankylosing spondylitis is a chronic, multisystem inflammatory disorder chiefly involving the sacroiliac joints and the axial skeleton. The term nonradiographic axial spondyloarthritis (nr-axSpA) refers to patients who exhibit clinical symptoms of ...

UK's Izana Bioscience tests rheumatoid arthritis drug in COVID-19 patients
https://www.reuters.com/article/us-health-coronavirus-therapy-izana/uks-izana-bioscience-tests-rheumatoid-arthritis-drug-in-covid-19-patients-idUSKBN21N0Z9

Apr 5th, 2020 - LONDON (Reuters) - UK-based biopharma company Izana Bioscience said it was testing its antibody therapy namilumab for the treatment of patients with rapidly worsening COVID-19 at the Humanitas Research Hospitals in Bergamo and Milan in Italy. Nami...

Increased Risk of Inflammatory Arthritis With Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/924275

Jan 28th, 2020 - NEW YORK (Reuters Health) - Patients with hidradenitis suppurativa (HS) face an increased risk of developing inflammatory arthritis, according to findings from a claims database. "We observed increased risks of developing ankylosing spondylitis, p...

see more →

Patient Education  51 results see all →